{'fraction_non_alphanumeric': 0.015252621544327931, 'fraction_numerical': 0.004289799809342231, 'mean_word_length': 5.727564102564102, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
CONTRADICTIONS IN THE SPHERE OF LEGAL REGULATION OF THE TURNOVER OF NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND THEIR PRECURSORS, WHICH ENTERED INTO FORCE IN 2022

Abstract. The turnover of narcotic drugs, psychotropic substances and their precursors in healthcare is regulated by a significant volume of legislative and legal acts. At the same time, since March 1, 2022, a number of new regulatory documents have been adopted, which define the requirements for the turnover of these substances. But, despite the comments made in previous publications, on the settlement of certain issues in this area within the framework of the regulatory guillotine, unfortunately, the new documents that have entered into force are not without serious shortcomings. These shortcomings can negatively affect the quality of medical and pharmaceutical services, since the presence of contradictions leads to an ambiguous interpretation of certain points of the approved legal norms. The study was conducted on the basis of a content analysis of the information base relevant at the time of studying the problem regulating the turnover of narcotic drugs, psychotropic substances and their precursors. Discrepancies and shortcomings were revealed on the following points: rules for maintaining special journals; registration of requirements and bill of lading requirements; the procedure for the release of narcotic drugs and psychotropic substances to medical organizations; the possibility of assigning these substances by individual entrepreneurs; individual issues of fixing the loss; return from temporary storage to main storage; storage conditions of thermolabile narcotic drugs, depending on the category of premises; accounting and destruction of precursors; as well as excessive requirements. The results of the analysis of the newly issued regulatory documents showed the need to make corrective changes in order to better understand the requirements of regulatory documents in the field of trafficking of narcotic drugs, psychotropic substances and their precursors for proper execution by practitioners.